first, are these compounds disclosed sufficiently in the 3rd party\'s application, (A26.4)
if yes, then your proposed compounds are not novel.
if no, then to invalidate that application, at least narrow it to those compounds disclosed sufficiently.
second, are your proposed compounds are selection inventions,
if yes, to show the inventive step.(A22.3) and then seek for cross-licensing.
fyi |